Double-blind randomized study of lonidamine and radiotherapy in head and neck cancer
- 1 April 1994
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 29 (1) , 45-55
- https://doi.org/10.1016/0360-3016(94)90225-9
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapyRadiotherapy and Oncology, 1992
- Concomitant boost technique using accelerated superfractionated radiation therapy for advanced squamous cell carcinoma of the head and neckCancer, 1992
- Inhibition of the recovery from potentially lethal damage by lonidamineBritish Journal of Cancer, 1984
- Radiosensitization of Meth-A Fibrosarcoma in Mice by LonidamineOncology, 1984
- Pharmacokinetics of Lonidamine after Oral Administration in Cancer PatientsOncology, 1984
- Lonidamine: A Hyperthermic Sensitizer of HeLa Cells in Culture and of the Meth-A Tumor in vivoOncology, 1984
- Effects of Lonidamine on Murine and Human Tumor Cells in vitroOncology, 1984
- Morphological and biochemical modifications of rat germ cell mitochondria induced by new antispermatogenic compounds: Studies in vivo and in vitroExperimental and Molecular Pathology, 1981
- Toxicological Studies on l-Substituted-Indazole-3-Carboxylic AcidsChemotherapy, 1981
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958